How AI Is Aiming at the Bad Math of Drug Development

Robert Marcus
Nov 29, 2021

Related news

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

Nov 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Four major impacts of artificial intelligence on healthcare

Jan 7
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Alphabet's VC Arm adds Senior Healthcare Partner

May 28
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Chamath Palihapitiya – Venture Capital – Silicon Valley Ponzi Scheme

Oct 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Alpha Connector - Robert Marcus - Founder, and CEO of Alpha10X

Nov 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Investment Into Biosciences Boomed, Could The Bubble Burst?

Mar 26
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

VC Firms Have Long Backed AI. Now, They Are Using It.

Nov 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

CapitalVX: A machine learning model for startup selection and exit prediction

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Arabesque launches the world’s first AI-powered ESG portfolio manager

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus